19:56 IST
BSE
Board Meeting Date
Vivimed Labs Board Meeting Date
Vivimed Labs scheduled a board meeting on July 17, 2026. The board will consider audited financial results for the period ending March 31, 2026.
Vivimed Labs Ltd
- Share price
- ₹6.59
- Market cap
- ₹54.64 Cr
- Revenue (annual)
- ₹69.99 Cr
- Net profit (annual)
- ₹-176.5 Cr
- P/E (TTM)
- -0.3×Sector 47.4×
- Promoter holding
- 7.57%-0.20% QoQ
- FII holding
- 1.64%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Insolvency Petition 4Board Meeting Date 4Other Announcement 2Results Correction 1Legal & Regulatory 1Financial Results 1Debt & Borrowing 1
Time
4 announcements with these filters
15:13 IST
NSE
Board Meeting Date
Vivimed Labs Board Meeting Date
Vivimed Labs Limited has postponed its board meeting originally scheduled for May 28, 2026. The meeting was intended to consider audited yearly financial results.
13:56 IST
BSE
Board Meeting Date
Vivimed Labs Board Meeting Date
Vivimed Labs scheduled a board meeting on May 28, 2026, to approve audited financial results. This advance notice provides transparency on the upcoming earnings disclosure timeline.
16:35 IST
NSE
Board Meeting Date
Vivimed Labs Board Meeting Date
Vivimed Labs scheduled a board meeting for May 28, 2026, to approve audited annual financial results. The trading window remains closed until May 31, 2026.